“What’s in a name?”–The implications of change in nomenclature for fatty liver disease from NAFLD to MAFLD to MASLD
| dc.contributor.author | Niriella, M.A. | |
| dc.date.accessioned | 2024-11-12T05:07:07Z | |
| dc.date.available | 2024-11-12T05:07:07Z | |
| dc.date.issued | 2024 | |
| dc.description | Not indexed | en_US |
| dc.description.abstract | No abstract available | en_US |
| dc.identifier.citation | Ceylon Medical Journal. 2024; 68(3): 91-94. | en_US |
| dc.identifier.issn | 2386-1274(Electronic) | |
| dc.identifier.issn | 0009-0875(Print) | |
| dc.identifier.uri | http://repository.kln.ac.lk/handle/123456789/28729 | |
| dc.language.iso | en | en_US |
| dc.publisher | The Sri Lanka Medical Association | en_US |
| dc.subject | Nomenclature | en_US |
| dc.subject | Fatty liver | en_US |
| dc.subject | Fatty liver disease | en_US |
| dc.subject | Steatotic liver disease | en_US |
| dc.subject | Metabolic dysfunction | en_US |
| dc.subject | NAFLD | en_US |
| dc.subject | MAFLD | en_US |
| dc.subject | MASLD | en_US |
| dc.title | “What’s in a name?”–The implications of change in nomenclature for fatty liver disease from NAFLD to MAFLD to MASLD | en_US |
| dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
- Name:
- “What’s in a name” – The implications of change in nomenclature for fatty liver disease.pdf
- Size:
- 33.51 KB
- Format:
- Adobe Portable Document Format
- Description:
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 52 B
- Format:
- Item-specific license agreed upon to submission
- Description: